Mirum Pharmaceuticals Statistics
Total Valuation
MIRM has a market cap or net worth of $3.59 billion. The enterprise value is $3.61 billion.
Important Dates
The last earnings date was Wednesday, August 6, 2025, after market close.
| Earnings Date | Aug 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
MIRM has 50.24 million shares outstanding. The number of shares has increased by 6.94% in one year.
| Current Share Class | 50.24M |
| Shares Outstanding | 50.24M |
| Shares Change (YoY) | +6.94% |
| Shares Change (QoQ) | +1.71% |
| Owned by Insiders (%) | 1.38% |
| Owned by Institutions (%) | 93.80% |
| Float | 39.99M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 8.11 |
| Forward PS | n/a |
| PB Ratio | 14.03 |
| P/TBV Ratio | 207.83 |
| P/FCF Ratio | 416.48 |
| P/OCF Ratio | 399.44 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 8.41 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 418.15 |
Financial Position
The company has a current ratio of 3.13, with a Debt / Equity ratio of 1.25.
| Current Ratio | 3.13 |
| Quick Ratio | 2.84 |
| Debt / Equity | 1.25 |
| Debt / EBITDA | n/a |
| Debt / FCF | 36.97 |
| Interest Coverage | -3.98 |
Financial Efficiency
Return on equity (ROE) is -24.19% and return on invested capital (ROIC) is -6.37%.
| Return on Equity (ROE) | -24.19% |
| Return on Assets (ROA) | -5.15% |
| Return on Invested Capital (ROIC) | -6.37% |
| Return on Capital Employed (ROCE) | -9.82% |
| Revenue Per Employee | $1.33M |
| Profits Per Employee | -$181,873 |
| Employee Count | 322 |
| Asset Turnover | 0.62 |
| Inventory Turnover | 4.15 |
Taxes
In the past 12 months, MIRM has paid $1.20 million in taxes.
| Income Tax | 1.20M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +73.42% in the last 52 weeks. The beta is 0.95, so MIRM's price volatility has been similar to the market average.
| Beta (5Y) | 0.95 |
| 52-Week Price Change | +73.42% |
| 50-Day Moving Average | 54.78 |
| 200-Day Moving Average | 47.22 |
| Relative Strength Index (RSI) | 79.30 |
| Average Volume (20 Days) | 783,610 |
Short Selling Information
The latest short interest is 6.63 million, so 13.21% of the outstanding shares have been sold short.
| Short Interest | 6.63M |
| Short Previous Month | 6.58M |
| Short % of Shares Out | 13.21% |
| Short % of Float | 16.59% |
| Short Ratio (days to cover) | 17.23 |
Income Statement
In the last 12 months, MIRM had revenue of $429.16 million and -$58.56 million in losses. Loss per share was -$1.20.
| Revenue | 429.16M |
| Gross Profit | 339.14M |
| Operating Income | -57.08M |
| Pretax Income | -107.43M |
| Net Income | -58.56M |
| EBITDA | -32.86M |
| EBIT | -57.08M |
| Loss Per Share | -$1.20 |
Full Income StatementBalance Sheet
The company has $304.55 million in cash and $318.90 million in debt, giving a net cash position of -$14.35 million or -$0.29 per share.
| Cash & Cash Equivalents | 304.55M |
| Total Debt | 318.90M |
| Net Cash | -14.35M |
| Net Cash Per Share | -$0.29 |
| Equity (Book Value) | 255.16M |
| Book Value Per Share | 5.10 |
| Working Capital | 308.60M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $9.00 million and capital expenditures -$368,000, giving a free cash flow of $8.63 million.
| Operating Cash Flow | 9.00M |
| Capital Expenditures | -368,000 |
| Free Cash Flow | 8.63M |
| FCF Per Share | $0.17 |
Full Cash Flow StatementMargins
Gross margin is 79.02%, with operating and profit margins of -13.30% and -13.65%.
| Gross Margin | 79.02% |
| Operating Margin | -13.30% |
| Pretax Margin | -13.37% |
| Profit Margin | -13.65% |
| EBITDA Margin | -7.66% |
| EBIT Margin | -13.30% |
| FCF Margin | 2.01% |
Dividends & Yields
MIRM does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -6.94% |
| Shareholder Yield | -6.94% |
| Earnings Yield | -1.63% |
| FCF Yield | 0.24% |
Dividend DetailsAnalyst Forecast
The average price target for MIRM is $73.89, which is 3.31% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $73.89 |
| Price Target Difference | 3.31% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 9 |
| Revenue Growth Forecast (5Y) | 25.29% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
MIRM has an Altman Z-Score of 2.22 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.22 |
| Piotroski F-Score | 4 |
